Diversified Trust’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33,236
Closed -$136K 889
2022
Q1
$136K Hold
33,236
﹤0.01% 767
2021
Q4
$119K Hold
33,236
﹤0.01% 800
2021
Q3
$121K Hold
33,236
﹤0.01% 757
2021
Q2
$145K Hold
33,236
0.01% 740
2021
Q1
$137K Sell
33,236
-3,420
-9% -$14.8K 0.01% 718
2020
Q4
$146K Sell
36,656
-13,523
-27% -$43.8K 0.01% 693
2020
Q3
$135K Buy
+50,179
New +$139K 0.01% 598

Other funds holding ATRS

Diversified Trust's ATRS Position: Q2 2022 in Review

Diversified Trust sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 33,236 shares — an estimated $136K sold.

Diversified Trust first reported a position in ATRS in Q3 2020 and held it in 7 quarters. The position peaked at $146K in Q4 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Diversified Trust reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Diversified Trust sold 33,236 Antares Pharma, Inc. shares in Q2 2022, an estimated $136K.
  • Diversified Trust first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 7 quarters.
  • Diversified Trust's Antares Pharma, Inc. position peaked at $146K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Diversified Trust's 13F filing for Q2 2022, filed 12 Jul 2022.